SightScore is a saliva test that looks at millions of genetic variants in the patient’s genome to create a personalized ...

Seonix Bio, a leader in the development of genetic testing for glaucoma, today announced the U.S. launch of SightScore, the ...

The asymptomatic nature of glaucoma makes it imperative to get consistent screening to catch the condition early. Catching glaucoma early through routine screening is the best way to get effective ...

and every 1-2 years for those for those with risk factors More frequent screening in consultation with an ophthalmologist for those at higher risk for glaucoma or other ocular diseases Open-angle ...

Up to 50% of glaucoma cases have a genetic component, a factor which could significantly change the screening recommendations and monitoring of patients – if they know their risk. Seonix Pty. Ltd. has ...

It is important to look for specific signs of vision loss in children, and be proactive about routine visits to an eye ...

What started as a ‘friendly conversation’ on the UNTHSC campus could lead to a breakthrough in treating glaucoma—the leading ...

“Knowing health concerns that could increase someone’s risk may help direct us to screening patients sooner or more ...

Nayanamritham 2.0 expands its scope to include screening for two major chronic eye diseases—glaucoma and age-related macular degeneration (AMD).